Paper41369698
Myxococcus fulvus, as a Potential Isolate to be used as a Future Biocontrol Agent.
Sharma A and 3 others. Curr Microbiol, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Myxococcus fulvus, as a Potential Isolate to be used as a Future Biocontrol Agent. Papers, record 41369698. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41369698
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biological Control Agents | Major topic |
| Antibiosis | Major topic |
| Plant Diseases | Major topic |
| Myxococcus | Major topic |
| Antifungal Agents | |
| Fusarium | |
| India | |
| Biofilms | |
| Soil Microbiology | |
| Ascomycota |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| AMAAS | National Bureau of Agricultural Insect Resources | PubMed |
Source PubMed
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20507532 | Aspergillus flavus: the major producer of aflatoxin. | Mol Plant Pathol | 2007 | https://conductscience.org/library/papers/20507532 | PubMed |
| 2 | 27756222 | Analysis and description of the stages of Aspergillus fumigatus biofilm formation using scanning electron microscopy. | BMC Microbiol | 2016 | https://conductscience.org/library/papers/27756222 | PubMed |
| 3 | 34683458 | The Predatory Myxobacterium Citreicoccus inhibens gen. nov. sp. nov. Showed Antifungal Activity and Bacteriolytic Property against Phytopathogens. | Microorganisms | 2021 | https://conductscience.org/library/papers/34683458 | PubMed |
| 4 | 10978544 | Biology and global distribution of myxobacteria in soils. | FEMS Microbiol Rev | 2000 | https://conductscience.org/library/papers/10978544 | PubMed |
| 5 | 30818644 | Interactions Between Myxobacteria, Plant Pathogenic Fungi, and Biocontrol Agents. | Plant Dis | 2002 | https://conductscience.org/library/papers/30818644 | PubMed |
| 6 | 28489498 | Fusarium oxysporum and the Fusarium Wilt Syndrome. | Annu Rev Phytopathol | 2017 | https://conductscience.org/library/papers/28489498 | PubMed |
| 7 | 32961612 | Antifungal and antibiofilm activities of the essential oil of leaves from Lippia gracilis Schauer against phytopathogenic fungi. | J Appl Microbiol | 2021 | https://conductscience.org/library/papers/32961612 | PubMed |
| 8 | 31065029 | A novel outer membrane β-1,6-glucanase is deployed in the predation of fungi by myxobacteria. | ISME J | 2019 | https://conductscience.org/library/papers/31065029 | PubMed |
| 9 | 8119858 | The soraphens: a family of novel antifungal compounds from Sorangium cellulosum (Myxobacteria). I. Soraphen A1 alpha: fermentation, isolation, biological properties. | J Antibiot (Tokyo) | 1994 | https://conductscience.org/library/papers/8119858 | PubMed |
| 10 | 31134579 | Biofilm characterization of Fusarium solani keratitis isolate: increased resistance to antifungals and UV light. | J Microbiol | 2019 | https://conductscience.org/library/papers/31134579 | PubMed |
| 11 | 18837103 | Chilli anthracnose disease caused by Colletotrichum species. | J Zhejiang Univ Sci B | 2008 | https://conductscience.org/library/papers/18837103 | PubMed |
| 12 | 22536 | Purification and properties of an extracellular protease from Myxococcus virescens. | J Bacteriol | 1978 | https://conductscience.org/library/papers/22536 | PubMed |
| 13 | 27907217 | Natural products from myxobacteria: novel metabolites and bioactivities. | Nat Prod Rep | 2017 | https://conductscience.org/library/papers/27907217 | PubMed |
| 14 | 33036496 | Natural Compound-derived Cytochrome bc1 Complex Inhibitors as Antifungal Agents. | Molecules | 2020 | https://conductscience.org/library/papers/33036496 | PubMed |
| 15 | 26010032 | Kinetics of biofilm formation by drinking water isolated Penicillium expansum. | Biofouling | 2015 | https://conductscience.org/library/papers/26010032 | PubMed |
| 16 | 34923648 | Myxobacteria from animal dung pellets collected from northwestern Himalayas: A new source of di-isobutyl phthalate. | J Basic Microbiol | 2022 | https://conductscience.org/library/papers/34923648 | PubMed |
| 17 | 9589062 | Cystothiazoles A and B, new bithiazole-type antibiotics from the myxobacterium Cystobacter fuscus. | J Antibiot (Tokyo) | 1998 | https://conductscience.org/library/papers/9589062 | PubMed |
| 18 | 31707075 | In depth natural product discovery - Myxobacterial strains that provided multiple secondary metabolites. | Biotechnol Adv | 2020 | https://conductscience.org/library/papers/31707075 | PubMed |
| 19 | 24512530 | Cytotoxic and antimicrobial activities of endophytic fungi isolated from Bacopa monnieri (L.) Pennell (Scrophulariaceae). | BMC Complement Altern Med | 2014 | https://conductscience.org/library/papers/24512530 | PubMed |
| 20 | 17578419 | Antifungal activity of essential oils against filamentous fungi determined by broth microdilution and vapour contact methods. | J Appl Microbiol | 2007 | https://conductscience.org/library/papers/17578419 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42388319 | Predatory Myxococcus fulvus strain KS01 confers biocontrol and growth promotion in cotton through multifaceted antifungal mechanisms. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42388319 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41369698
GET https://conductscience.org/api/papers/v1/41369698/references?page=2